spacer
home > pmps > summer 2002 > developing custom adhesive systems for transdermal drug delivery products
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Developing Custom Adhesive Systems for Transdermal Drug Delivery Products

Pharmaceutical companies in search of unique pressure-sensitive adhesive systems for their transdermal drug delivery (TDD) products are turning to specialty adhesives manufacturers to carry out research and development, testing, materials qualification, manufacturing, quality and other product development tasks. Trends suggest that adhesives manufacturers are forming partnerships with pharmaceutical companies as part of the product development process that ultimately includes manufacturing adhesive products to the relevant pharmaceutical current Good Manufacturing Practices (cGMPs). This article also discusses the technological advances that are occurring in terms of types of transdermal patch, adhesive properties and specialised components in transdermal drug delivery systems (TDDS).

Transdermal Drug Delivery Systems

The use of TDDS continues to gain market acceptance as a selected method of drug administration. The success of products that deliver materials such as nicotine for smoking cessation, nitroglycerin for angina, oestradiol and testosterone for hormone replacement therapy, and oestrogen and progesterone for birth control has ensured that the TDDS market is a strong industry segment with many more drug actives being formulated for transdermal delivery methods.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Melinda Hopp, Director of Marketing at Adhesives Research, Inc. Melinda Hopp has served as Director of Marketing at Adhesives Research, Inc. for the past six years. She previously worked for Southern New England Telephone as Director of Business Development; Duracell, Inc. (a division of Gillette Company) as Director of Market Development; and Novo Laboratories USA (a former division of NovoNordisk, Denmark) as Director of Market Research.
She started her career as a Research Chemist with Lehn & Fink Products (then a division of Sterling Drug). She has a BA in Biology/Chemistry, an MA in Science and an MBA from Fairleigh Dickinson University in New Jersey, US.

spacer
Melinda Hopp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PharmaFluidics awarded VLAIO research grant

Ghent, Belgium – June 2, 2020 PharmaFluidics NV, innovative player in the field of analytical chromatography with its unique high-resolution µPAC™ micro-Chip technology, announces that it has been awarded a € 613 k grant from Flanders’ Innovation & Entrepreneurship Agency (VLAIO). The grant will run over two years and will support the further optimization of PharmaFluidics’ manufacturing flow, and to develop complementary new surface-modified µPAC™ products.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement